Translational Development Acquisition Corp. (TDACW)
Market Closed
16 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
1. 90
-0.8
-29.6296%
$
271.91M Market Cap
- P/E Ratio
- Div Yield
800 Volume
- Eps
$ 2.7
Previous Close Want to track TDACW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Translational Development Acquisition Corp. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Daniel L. Lippincott Karpus Management Inc. | 603,425 | $121,181.44 | $1.33M | $1.21M | 995.49% |
| SK Steven Katznelson Radcliffe Capital Management LP | 505,514 | $139,729.56 | $1.11M | $972,401.24 | 695.92% |
| BO Brian Oliveira Clear Street Group Inc. | 166,777 | $48,365.02 | $383,587.1 | $335,222.08 | 693.11% |
